Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGK1 | P00558 | 2/20 | 0.43 |
| ▸ | KMO | O15229 | 1/20 | 0.40 |
| ▸ | TRPM5 | Q9NZQ8 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
| ▸ | CACNA1H | O95180 | 9/20 | 0.38 |
| ▸ | MAOB | P27338 | 2/20 | 0.38 |
| ▸ | MAT2A | P31153 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | KDM1A | O60341 | 1/20 | 0.36 |
| ▸ | BCDIN3D | Q7Z5W3 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL33526553 | 0.93 | PGK1 (0.43) | PGK1KMOTRPM5HTR2AHTR2C | |
| SCHEMBL31602718 | 0.80 | KDM1A (0.36) | CACNA1HKDM1A | |
| SCHEMBL12600620 | 0.76 | HTR2A (0.36) | PGK1KMOHTR2AHTR2C | |
| SCHEMBL30711996 | 0.75 | ALDH1A1 (0.41) | BCDIN3D | |
| SCHEMBL23357368 | 0.75 | ALDH1A1 (0.41) | BCDIN3D | |
| Hydrochloric Acid SCHEMBL27190695 | 0.74 | KDM1A (0.36) | HTR2AHTR2CCACNA1HKDM1A | |
| SCHEMBL20056124 | 0.74 | HTR2A (0.45) | PGK1TRPM5HTR2AHTR2CCACNA1H | |
| SCHEMBL31752152 | 0.72 | ALDH1A1 (0.40) | CACNA1HMAOA | |
| SCHEMBL14745880 | 0.71 | PRKCI (0.44) | PGK1KMOCACNA1HMAOBMAT2A | |
| SCHEMBL31602858 | 0.70 | HTR2A (0.41) | KMOTRPM5HTR2AHTR2CMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | LILLY CO ELI (US) | 2026-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | GIPR, GLP1R, GPR119 | PGK1 4072/4885KMO 2727/4885TRPM5 1005/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.